|
Volumn 66, Issue 1, 2009, Pages 8-
|
Tapentadol approved as pain reliever
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MONOAMINE OXIDASE INHIBITOR;
MU OPIATE RECEPTOR AGONIST;
NORADRENALIN;
OPIATE RECEPTOR;
TAPENTADOL;
3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)PHENOL;
ANALGESIC AGENT;
PHENOL DERIVATIVE;
ADULT;
ANALGESIA;
DIZZINESS;
DRUG APPROVAL;
DRUG CONTRAINDICATION;
DRUG INDICATION;
DRUG MARKETING;
DRUG RELEASE;
FOOD AND DRUG ADMINISTRATION;
HEADACHE;
HUMAN;
NAUSEA;
NOTE;
PAIN;
PRIORITY JOURNAL;
SOMNOLENCE;
TABLET FORMULATION;
UNITED STATES;
VOMITING;
CHEMISTRY;
ADULT;
ANALGESICS;
DRUG APPROVAL;
HUMANS;
PAIN;
PHENOLS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 62449107509
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/news090001 Document Type: Note |
Times cited : (6)
|
References (0)
|